Cellectricon
PrivateLast Round
VC Round
Feb 21, 2008
Total Funding Raised
$11.87M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cellectricon is a life sciences company that provides neuroscience drug discovery services intended to decipher disease mechanisms and identify and validate novel targets.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellectricon Comparables
Compare Cellectricon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| E-Phy-Science | 83% | |
| NeuroProof | 83% | |
| Metrion Biosciences | 81% |
Cellectricon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 21, 2008 | ||||
| Series B | May 26, 2004 | ||||
| Series A | Jul 11, 2002 |
Key People
Founding team and executive leadership
Cellectricon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investor Growth Capital | VC Round, Series A, Series B |
| Karolinska Development AB | Series A, Series B |
| Dunross & Co | VC Round |
| InnovationsKapital Nordic Advisors | Series B |
| InnovationsKapital | VC Round, Series A |
| Ägir Invest | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 235% MoM.
- Jan 21, 2026
Monthly visitors grew 47% MoM.
Cellectricon Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cellectricon's valuation, stock price, and market status.
Is Cellectricon a public or private company?
Cellectricon is a private company.
What is the current stock price of Cellectricon?
Cellectricon is a private company with no public stock price. No recent secondary market data is available.
How much is Cellectricon worth (valuation)?
Valuation information for Cellectricon is not publicly available.
Can I buy Cellectricon stock?
Cellectricon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cellectricon's last funding round?
Cellectricon's most recent funding round was VC Round on February 21, 2008.
Who are the main investors in Cellectricon?
Key investors in Cellectricon include Investor Growth Capital, Karolinska Development AB, InnovationsKapital Nordic Advisors.
Will Cellectricon IPO soon?
No public IPO plans have been announced for Cellectricon.
How can I track Cellectricon secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellectricon's secondary market activity and sign up for updates.